📅 PUBMED DAILY TRIAGE — 2026-05-04 (Monday)
Window: 2026-05-03T09:00Z → 2026-05-04T09:00Z (CRDT) Topics scanned: 10 | Candidates evaluated: ~96 | Articles kept: 12 High priority: 1 | Standard: 11 | Low/archive: 0 | Unsolicited finds: 1 Run status: ✅ SUCCESS
🔴🟠 HIGH PRIORITY — Best Finds by Topic
Rare Diseases with High Unmet Need / Novel Therapeutics
TR-2026-05-04-001 / PMID 42070995 · Shifting Towards Empagliflozin First-Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real-World Study · 7/10 🟠 NOVEL_TREATMENT
Nationwide Turkey real-world study (N=42 GSD Ib patients) demonstrates empagliflozin first-line monotherapy significantly outperforms G-CSF: fewer infections, hospitalizations, IBD episodes, and better weight gain — even without ANC normalization. SGLT2i repurposing confirmed as clinically superior first-line strategy for this ultra-rare life-limiting disease. J Inherit Metab Dis.
(NOVEL_TREATMENT flag → HIGH despite score 7)
🟢⚪ STANDARD (5–7) — Top by Topic
Hematologic Malignancies (AML, MDS, CLL, MPN, Lymphoma)
- TR-2026-05-04-002 / PMID 42071259 · Targeting XPO1 in AML: From biology to clinical translation · 6/10 · Treatment Innovation | Clin Transl Med May 2026 — Comprehensive review of selinexor/eltanexor SINE inhibitors; NPM1/DEK::NUP214/SF3B1 biomarker-guided populations identified; venetoclax combination strategies discussed.
- TR-2026-05-04-007 / PMID 42071165 · Lactylation/phase separation genes in DLBCL prognosis · 5/10 · Genomics/Precision Medicine — 4-gene prognostic model validated in N=1310 external DLBCL cohort; immune microenvironment correlation; bioinformatics-only.
Early Cancer Detection / Prevention
- TR-2026-05-04-012 / PMID 42070373 · Cost-effectiveness of HPV vaccination in Jordan: a modelling study · 6/10 · Prevention 🟢 NEAR_TERM_IMPLEMENTABLE — Single-dose Cecolin cost-saving (97% probability), prevents >50% cervical cancer cases; directly policy-actionable for Jordan/MENA. Vaccine May 2026.
- TR-2026-05-04-009 / PMID 42068200 (deferred) · cfDNA in MASLD: genomic instability to epigenetic signatures · 5/10 · Diagnostics — Review of cfDNA biomarkers (mtDNAcn, CNVs, methylation, fragmentomics) for non-invasive MASLD staging. Hepatol Res.
Precision Oncology / Genomic Medicine
- TR-2026-05-04-003 / PMID 42071190 · Aumolertinib in NSCLC with uncommon EGFR exon 19 deletions: dual-center study · 7/10 · Genomics/Precision Medicine 🟢 NEAR_TERM_IMPLEMENTABLE — N=118, dual-center retrospective + molecular docking; aumolertinib mPFS 15.9 months with consistent cross-subtype efficacy vs osimertinib's subtype-dependent performance. BMC Cancer.
- TR-2026-05-04-010 / PMID 42068156 (deferred) · Single-cell HNSCC heterogeneity: subtypes and 25-gene MCScore for ICI response · 6/10 · Genomics/Precision Medicine — 181,003 cells integrated, 3 molecular subtypes; 25-gene MCScore predicts ICI response; MS-2 (HPV+/immune-enriched) best outcomes. IUBMB Life.
- TR-2026-05-04-008 / PMID 42071201 · Cytokines and cancer-associated fibroblasts · 5/10 · Treatment Innovation — J Hematol Oncol comprehensive CAF-cytokine review with precision oncology therapeutic framework; no new primary data.
Novel Therapeutics
- TR-2026-05-04-011 / PMID 42068188 (deferred) · Curcumin-Mg/GelMA hydrogel for dual aPD1 delivery post-microwave ablation in lung cancer · 5/10 · Drug Development ⚪ PROMISING_PRELIMINARY — Preclinical; innovative dual-function hydrogel concept (pleural sealing + immune modulation); non-human cap applied. Adv Healthc Mater.
Cardiovascular-Metabolic
- TR-2026-05-04-004 / PMID 42071205 · TyG-frailty index and cardiometabolic multimorbidity: CHARLS prospective cohort · 6/10 · Diagnostics — N=2961, HR 7.86 for highest TyG-FI quartile; ML AUC 0.81 (RANGER); TyG-FI outperforms components alone for CMM prediction. Cardiovasc Diabetol.
- TR-2026-05-04-001 / PMID 42070995 (also listed above as HIGH)
Rare Diseases
- TR-2026-05-04-005 / PMID 42070974 · Barth syndrome survival and clinical progression: N=502 global registry · 7/10 · Public Health 🟡 UNDERSERVED_POPULATION — >80% known global BTHS cases; 59% transplant-free survival <5 years; heart transplant (HR 0.316) and developed-country access protective; first comprehensive lifespan natural history. J Inherit Metab Dis.
💡 UNSOLICITED FINDS
TR-2026-05-04-006 / PMID 42071269 · Higher Daytime Light Exposure Predicts Lower Risk of GI Cancer Incidence and Mortality · 7/10 ⚪ PROMISING_PRELIMINARY UK Biobank prospective N=89,069; objectively measured daytime light (≥1916 lux) → GI cancer incidence HR 0.87 and mortality HR 0.76; pancreatic cancer mortality HR 0.47 (strongest). Predictive ability exceeded diet, sleep quality, alcohol. Circadian alignment as novel cancer prevention lever — warrants follow-up. Int J Cancer.
📊 TODAY'S BREAKDOWN
By research category:
- Treatment Innovation: 4
- Genomics/Precision Medicine: 4
- Diagnostics: 2
- Prevention/Public Health: 2
By evidence maturity:
- Validated: 5 (42070995, 42071190, 42071205, 42070974, 42070373)
- Exploratory: 7 (remainder)
- Potentially Practice-Changing: 0
By watchlist topic (reviewed / kept / highest score):
| Topic | Reviewed | Kept | Best Score |
|---|---|---|---|
| Hematologic malignancies | 10 | 2 | 6 |
| CBC/ML hematology | 0 | 0 | 0 |
| Early cancer detection | 5 | 2 | 6 |
| AI/ML diagnostics | 8 | 0 | 3 |
| Precision oncology | 10 | 3 | 7 |
| Novel therapeutics | 10 | 3 | 7 |
| Cardiometabolic | 8 | 2 | 7 |
| Aging/longevity | 10 | 0 | 2 |
| Rare diseases | 4 | 2 | 7 |
| Sentinel | 8 | 1 | 7 |
By source type: Peer-reviewed: 12 | Preprint: 0
Topics with zero 8+ articles this run: ALL (no article independently reached score 8; 1 HIGH via NOVEL_TREATMENT flag)
Topics with zero kept articles this run: CBC/ML hematology, AI/ML diagnostics, Aging/longevity
🔧 RUN NOTES
- Window expansion: Not triggered — 12 articles kept (>5 threshold)
- Deferred PMIDs resolved: All 5 from 2026-05-03 processed; 3 kept (42068200, 42068156, 42068188), 2 discarded (42067982 plant disease, 42068170 below threshold)
- CBC/ML hematology: 11th consecutive EMPTY window — STRONGLY recommend reviewing query or acknowledging topic sparsity in this CRDT window
- AI/ML diagnostics: All 8 candidates were book chapters from Adv Exp Med Biol Vol. 1504 batch — likely large publisher batch event; not substantive misses
- Aging/longevity: 56 esearch results but first 10 dominated by pest management / animal biology (insect heat shock proteins, laying hens); query should add
AND humans[MeSH]in future runs - Highest score today: 7/10 (multiple articles); 0 articles hit 8+
- Monday recovery confirmed: 130 sentinel results vs weekend lag of prior run
- Alert emitted: 1 (PMID 42070995 — GSDIb/empagliflozin NOVEL_TREATMENT)
- Rolling 7-day topics with zero HIGH articles: CBC/ML hematology (11 days); AI/ML diagnostics (consistent underperformance); Aging/longevity (requires query refinement)